J. Newman

Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products

S. Devine, Gretta L. Stritesky, J. Auletta, 2020, Transplantation and Cellular Therapy.

Neither COVID-19, Nor Cryopreservation, Prevented Allogeneic Product Infusion: A Report from the National Marrow Donor Program

S. Devine, H. Stefanski, H. Pham, 2021, Frontiers in Immunology.

Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2

B. Charleston, T. Peacock, W. Barclay, 2021, medRxiv.